Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys - Test2 - elhamkhani - TriplyDB

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

http://www.wikidata.org/entity/Q33269796

about

Lectin-dependent enhancement of Ebola virus infection via soluble and transmembrane C-type lectin receptors Vesicular stomatitis virus-based ebola vaccine is well-tolerated and protects immunocompromised nonhuman primates Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with vero cells-adapted hogan strain of Marburg virus Sustained protection against Ebola virus infection following treatment of infected nonhuman primates with ZMAb Emerging targets and novel approaches to Ebola virus prophylaxis and treatment Delayed treatment of Ebola virus infection with plant-derived monoclonal antibodies provides protection in rhesus macaques Ebola haemorrhagic fever Ebolavirus vaccines for humans and apes Convalescent plasma: new evidence for an old therapeutic tool?Filoviruses: One of These Things is (not) Like the Other Ebola Virus Disease (The Killer Virus): Another Threat to Humans and Bioterrorism: Brief Review and Recent Updates Mouse models for filovirus infections Structural basis for differential neutralization of ebolaviruses Antibodies against viruses: passive and active immunization Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it Ebolavirus glycoprotein structure and mechanism of entry Complex of a Protective Antibody with Its Ebola Virus GP Peptide Epitope: Unusual Features of a Vλx Light Chain Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor Structural and molecular basis for Ebola virus neutralization by protective human antibodies Stability of isolated antibody-antigen complexes as a predictive tool for selecting toxin neutralizing antibodies Cell-targeting antibodies in immunity to Ebola Antibodies for biodefense Ad35 and ad26 vaccine vectors induce potent and cross-reactive antibody and T-cell responses to multiple filovirus species Production of Potent Fully Human Polyclonal Antibodies against Ebola Zaire Virus in Transchromosomal Cattle Enhanced potency of a fucose-free monoclonal antibody being developed as an Ebola virus immunoprotectant.Anti-Ebola therapies based on monoclonal antibodies: current state and challenges ahead.Discovery of an antibody for pan-ebolavirus therapy Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus Demonstration of cross-protective vaccine immunity against an emerging pathogenic Ebolavirus Species Identification of continuous human B-cell epitopes in the VP35, VP40, nucleoprotein and glycoprotein of Ebola virus Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product.Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein.Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever.Human Ebola virus infection in West Africa: a review of available therapeutic agents that target different steps of the life cycle of Ebola virus.Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.An update on the use of antibodies against the filoviruses.Structures of protective antibodies reveal sites of vulnerability on Ebola virus.Tackling Ebola: new insights into prophylactic and therapeutic intervention strategies.Evasion of the interferon-mediated antiviral response by filoviruses.Impact of Ebola mucin-like domain on antiglycoprotein antibody responses induced by Ebola virus-like particles.

P2860

Q21090770-92B77D8E-922F-476E-B27F-2BF8D8AB4351 Q21131585-3926C7C1-6F89-4984-B151-7EDE8EFBC975 Q21134043-55BFEA68-D1A0-4064-9DCF-36954ED9C4A8 Q24594601-6BBCE914-50A6-4338-A0E6-E2C35AF57128 Q24597625-72E039A4-7D6B-4BBB-9CD7-651AA19A80FC Q24612811-E276CF70-3A05-4872-9DF8-621D28A8E46F Q24629338-F4BCA881-0431-4423-82EA-A5E801C55F87 Q24631696-D56DAA63-1E9D-4E57-B42B-EF4D0991FFA2 Q26775412-C8752D44-CEB1-4C17-BDD4-D4843D7E4D9E Q26783063-199E4AFF-3B2E-443C-BBE0-7D67AD19D539 Q26798860-6304EB6F-C595-42FB-88B9-EB1E2E3F08B2 Q27011569-874AAE24-8DFF-477D-9446-697B8BBCF059 Q27014910-180FB3D3-8FB5-4D18-BCAC-2126DCBA72AA Q27489392-E8FE4DE8-26C1-4E63-9FD8-D0C0025B0F40 Q27489891-8B75064E-CC57-4BC8-9A59-D6BAFAF55207 Q27490991-A06E9AAC-1E76-4229-9111-82D59CEAE901 Q27649064-A642F4BC-AE66-44DB-9B4C-5299AAD98843 Q27651112-15A93147-CB49-4CAC-AD77-BB28A1A4A1EC Q27704188-217CFB06-CC2B-4F83-99FC-1CEC0FA38AAE Q27728106-CA80C6F5-554A-4AA4-91B9-2696EB7496FA Q28068972-9DAB92D7-7017-4E62-AE95-B0EC40FB3851 Q28394941-200167CF-D311-493C-8747-B7845387B5D6 Q28485505-2EF9AFF2-F245-499D-9AF6-028430E1E487 Q28603849-C5FB0F38-B66C-443B-A571-1D66EABF8E72 Q30224854-52D0E273-7DB0-4C88-9C38-A8C397D5EE60 Q30252022-8D690D1F-8765-441A-AFEC-B224D4107B0B Q30385927-606BD706-4625-46C0-8F04-EF49D8733E38 Q33417197-CE037BFC-4E52-46FC-8DB5-482B93112B93 Q33587515-A52B5803-C3F4-4268-975D-45B07ACD2FF7 Q33733844-EE26966F-1E6F-4E33-9348-437D0A870BAF Q33826350-15874727-8DCD-4458-833C-8B6EB7AB43FC Q34115190-E0F8AAFC-B78B-49A0-8C33-DB827FA76CE6 Q34257290-8E7CC5F7-B046-43E8-A4C8-3B44D6F7B007 Q34463780-E91547F5-2B1B-4CFA-8FDF-D7F54E8809F6 Q34598925-D5DBDF2E-D782-48A3-8C6D-D270282E157D Q34657170-3359889A-E66C-479A-89BF-85AAB9442C9B Q34661120-04C53398-ED76-4982-AD21-15CD93BDFAEB Q34971349-D6C3142D-7836-4CF1-AD98-B1B19A49E35B Q35260239-43A5E75B-C177-4DC1-AF8A-B96FA00D7644 Q35299756-5FA7320D-DE90-4B5A-A127-CA03212F784D

P2860

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

http://www.wikidata.org/entity/Q33269796

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

@ast

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

@en

type

label

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

@ast

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

@en

prefLabel

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

@ast

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

@en

P1433

Q33269796-7192B25C-FBF1-43B3-A9F9-8ED9760DEC74

P1476

Q33269796-6C5C73A6-D795-4F83-8A60-6120F7B72A94

P2093

Q33269796-232C6263-498F-4592-B164-7EF77DC65FD8

Q33269796-2A1F9F02-0C71-44E5-A40C-3C9B39CB1BEE

Q33269796-4DB2C27E-89AF-4F7F-BCB3-D72F2135B22D

Q33269796-5F7F3C09-B54E-44DE-80F7-1BA32B30F22F

Q33269796-B96244D8-9B1F-4D66-9DA6-683E60079262

Q33269796-F126039D-F440-4264-9B86-FD2541AEF530

P2860

Q33269796-024F7546-BDCE-45B8-ADE1-2CE55622282A

Q33269796-3061DF49-D53B-41C1-A73C-85A7CEF2AC70

Q33269796-34B0DA69-2F9E-49FF-9C89-08FC1E1B49BA

Q33269796-39260870-C090-4324-9979-D8FF752E5E4E

Q33269796-395FDA7B-9B7D-4AEE-A990-6C53FB27242F

Q33269796-3CE9151E-1436-4CD2-AEB4-926EEF228E0D

Q33269796-4279CC9B-668C-4E29-9187-4292A14E5CB0

Q33269796-452B591E-99C8-471F-AEDF-53F0AC701515

Q33269796-4C0CBFF5-0A1F-4BFB-9A47-C8C6424A03DD

Q33269796-4EAE0543-06BC-4008-B29A-DA56EC72D695

P304

Q33269796-9BE8792A-8E15-403B-882E-D8F21B70745A

P31

Q33269796-5F63E899-60D6-44B9-86BD-07D8D63AE952

P356

Q33269796-0BA66644-F902-41A5-BE3F-36203197E931

P433

Q33269796-838471D6-608F-4588-9705-6F79C17E36A3

P478

Q33269796-74882F4D-DF28-40C5-9E48-8427CC058593

P50

Q33269796-D85D45F7-A3C3-4C0B-AB37-C1831C7F47F8

Q33269796-EE275AF6-9748-4E73-ADC2-3254EB1C62BB

P577

Q33269796-A52EBE3E-55C2-4F57-9986-A6450B5C9DBF

P5875

Q33269796-976D7CD5-0AB7-422B-A1D5-B591C5659D49

P698

Q33269796-326C35F9-268E-46A6-B8AA-B092DA75A0BA

P921

Q33269796-151B1A16-E581-4DD7-8C68-37C666713D7E

Q33269796-94359985-E4FD-4F86-BABE-265B92D21768

P932

Q33269796-DF030701-0159-4633-99C6-11FCDF7A47BB

P356

JOURNAL.PPAT.0030009

P1433

P1476

Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys

@en

P2093

Dennis R Burton

http://www.w3.org/2001/XMLSchema#string

Joan B Geisbert

http://www.w3.org/2001/XMLSchema#string

Kelly J Davis

http://www.w3.org/2001/XMLSchema#string

Nancy J Sullivan

http://www.w3.org/2001/XMLSchema#string

Paul W H I Parren

http://www.w3.org/2001/XMLSchema#string

Wendelien B Oswald

http://www.w3.org/2001/XMLSchema#string

P2860

Ebola virus can be effectively neutralized by antibody produced in natural human infection.

Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/human immunodeficiency virus at serum levels giving complete neutralization in vitro

Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

The antiviral activity of antibodies in vitro and in vivo.

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates.

Antibody prophylaxis and therapy against Nipah virus infection in hamsters.

Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice.

Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. International Scientific and Technical Committee.

Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.

P304

e9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PPAT.0030009

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

Peter B. Jahrling

Thomas W Geisbert

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6565323

http://www.w3.org/2001/XMLSchema#string

P698

17238286

http://www.w3.org/2001/XMLSchema#string

P921

P932

1779296

http://www.w3.org/2001/XMLSchema#string